TD Cowen analysts adjusted their outlook on Biogen (NASDAQ:BIIB) shares, reducing the price target to $200 from the previous $275, while sustaining a Buy rating on the stock. The revision reflects ...

TD Cowen reaffirmed its Buy rating for Adyen NV (AS:ADYEN:NA) (OTC: ADYYF), with a consistent price target set at EUR1,700.00. The endorsement follows Adyen's robust financial performance in the ...

Analysts at TD Cowen started coverage on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report) in a research note issued on Tuesday, MarketBeat.com reports. The firm set a “buy” rating ...

The widely followed cryptocurrency analyst Benjamin Cowen is warning that Ethereum (ETH) could slide further against Bitcoin ...

President Donald Trump appointed William Cowan as acting general counsel of the National Labor Relations Board Monday evening ...

The analysts say a bundle is a better model for traditional TV giants like WBD, Disney, and Paramount. Netflix is another ...

周四，TD ...

TD ...

例如，HPV疫苗的全球市场正在快速变化，尤其是中国市场。由于疫情的影响和政策的调整，默克在中国的疫苗交付时程备受关注。分析人士指出，如果默克未能及时适应亚太地区日益变化的市场需求，其市场份额可能会受到威胁。此时，TD Cowen的信心下滑和目标价的下调也不无道理。

TD Cowen analyst Jared Levine raised the firm’s price target on Paylocity (PCTY) to $242 from $228 and keeps a Buy rating on the shares. The ...

Investing.com -- TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech company completed its $600 million acquisition of Ambry ...

TD Cowen lowered the firm’s price target on Skyworks (SWKS) to $75 from $90 and keeps a Hold rating on the shares. The firm said the company’s ...